Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.34 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.32 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4557747 | 1.00 | PTPN1 (0.34) | PTPN1PTPN2CXCR4 | |
| SCHEMBL3226863 | 0.85 | PTPN1 (0.44) | PTPN1PTPN2 | |
| SCHEMBL3221310 | 0.85 | PTPN1 (0.44) | PTPN1PTPN2 | |
| SCHEMBL2936665 | 0.85 | PTPN1 (0.44) | PTPN1PTPN2 | |
| SCHEMBL3208787 | 0.83 | PTPN1 (0.45) | PTPN1PTPN2 | |
| SCHEMBL3226441 | 0.77 | PTPN1 (0.45) | PTPN1PTPN2 | |
| SCHEMBL3226456 | 0.77 | PTPN1 (0.45) | PTPN1PTPN2 | |
| SCHEMBL2930305 | 0.75 | PTPN1 (0.45) | PTPN1PTPN2 | |
| SCHEMBL3226502 | 0.75 | PTPN1 (0.45) | PTPN1PTPN2 | |
| SCHEMBL3213345 | 0.74 | PTPN1 (0.48) | PTPN1PTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2089026-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY | Novartis AG (CH) | 2009-08-19 | — | — | EP | disclosed |
| WO-2008070552-A2 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE PROMOTION OF PHYSIOLOGICAL CARDIAC HYPERTROPHY | NOVARTIS AG (CH) | 2008-06-12 | — | — | WO | disclosed |
| WO-2008067527-A1 | INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE FOR THE TREATMENT OF MUSCLE ATROPHY AND RELATED DISORDERS | NOVARTIS AG (CH) | 2008-06-05 | — | — | WO | disclosed |